We are an established provider of preclinical consultancy services and have worked with a huge number of academic labs, start-ups, small- and mid-size pharmaceutical and chemical companies, venture capital organizations and other investors. Our portfolio of services covers all aspects of the preclinical phase of drug and medical device development, from the scientific evaluation and selection of candidate compounds, through the planning and execution of entire preclinical development programs, to the support of regulatory interactions. Our primary focus is a partnership with our clients and the delivery of highest scientific quality, without ever losing sight of the big picture and economic conditions.